Detail akcie Bure Equity online

Business Summary: Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Bure Equity AB revenues increased 22% to SEK246M. Net loss totaled SEK4.1B vs. income of SEK7.03B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Investment Portfolio segment loss totaling SEK4.11B vs. income of SEK7B. Basic Earnings per Share excluding Extraordinary Items decreased from SEK94.78 to -SEK55.29.